Speaker illustration

Doctor Rene Rettl

Medical University of Vienna, Vienna (Austria)

Two-dimensional speckle-tracking echocardiography in tafamidis-treated patients with transthyretin amyloid cardiomyopathy: a glimmer of hope for viable therapy monitoring?

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis

Thumbnail

Cardiac imaging in tafamidis-treatment patients with transthyretin amyloid cardiomyopathy

Event: ESC Congress 2021 - The Digital Experience

Topic: Infiltrative Myocardial Disease

Session: Myocardial and pericardial disease e-posters

Thumbnail

Quantification of myocardial amyloid deposition in tafamidis-treated patients with transthyretin amyloid cardiomyopathy

Event: ESC Congress 2021 - The Digital Experience

Topic: Infiltrative Myocardial Disease

Session: Myocardial and pericardial disease e-posters

Thumbnail

Effects of tafamidis on exercise capacity, cardiac function and myocardial amyloid deposition in patients with transthyretin amyloid cardiomyopathy

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Treatment

Session: Chronic Heart Failure ePosters

Thumbnail

Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy

Event: ESC CONGRESS 2019

Topic: Treatment

Session: Inflammatory, infiltrative and cardiomyopathy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk